Biomarkers of Surgical Anastomotic Stress: Current Evidence and Future Directions

Abstract

Surgical anastomoses, critical to many gastrointestinal and vascular procedures, are vulnerable to complications such as leakage and impaired healing. Early detection of anastomotic stress is essential for reducing morbidity and mortality. Recent advances have identified several biomarkers indicative of anastomotic integrity and stress, offering clinicians the potential for timely intervention. This review synthesizes current evidence on the epidemiology, pathophysiology, and clinical relevance of anastomotic biomarkers, discusses their diagnostic and prognostic value, and highlights recent advances and recommendations for clinical practice.

Introduction

Anastomotic failure remains a significant complication in surgical practice, particularly in gastrointestinal and vascular procedures, with profound implications for patient outcomes. Despite advances in surgical technique and perioperative care, the incidence of anastomotic leakage and related complications has not declined substantially. The identification of objective biomarkers that reflect anastomotic stress or impending failure could transform perioperative management by enabling earlier diagnosis, risk stratification, and targeted intervention. This article provides a comprehensive overview of the most promising biomarkers, their mechanisms, clinical utility, and incorporation into current management pathways.

Epidemiology / Disease Burden

Anastomotic leaks are reported in 2-10% of colorectal surgeries and up to 30% in high-risk esophageal and gastric procedures. The burden is amplified by increased morbidity, prolonged hospital stays, reoperations, septic complications, and a marked rise in perioperative mortality. The economic impact includes higher healthcare resource utilization and longer-term consequences such as stoma formation and impaired quality of life. Standard clinical and radiological assessments often lag behind the actual onset of anastomotic compromise, underscoring the need for sensitive and specific biomarkers to guide early intervention and improve outcomes.

Pathophysiology

Anastomotic healing is a complex, multifactorial process involving inflammation, tissue remodeling, angiogenesis, and epithelialization. Disruption of these processes by ischemia, infection, or technical factors can precipitate anastomotic stress and subsequent leakage. At the molecular level, local and systemic inflammatory mediators, matrix metalloproteinases (MMPs), cytokines such as interleukin-6 (IL-6), C-reactive protein (CRP), and procalcitonin (PCT) have been implicated in the pathogenesis of anastomotic dehiscence. Ischemia-reperfusion injury, oxidative stress, and dysregulated immune responses further exacerbate tissue breakdown and impair collagen synthesis, providing a mechanistic rationale for the observed biomarker changes.

Risk Factors

Established risk factors for anastomotic stress and failure include advanced age, malnutrition, obesity, diabetes mellitus, steroid use, neoadjuvant therapy, and intraoperative technical errors. Tumor location, tension on the anastomosis, inadequate blood supply, and pre-existing infection significantly increase the risk. Biomarkers may serve as adjuncts to traditional risk stratification tools, identifying patients with subclinical inflammation or occult ischemia who may benefit from tailored perioperative strategies.

Clinical Features

Early clinical signs of anastomotic compromise such as fever, tachycardia, abdominal pain, and localized peritonism are often nonspecific and may appear late in the course of dehiscence. Laboratory markers such as leukocytosis and elevated CRP are commonly used but lack sensitivity and specificity. The search for more reliable biomarkers aims to distinguish physiological postoperative changes from pathological responses indicative of anastomotic stress.

Diagnosis

Traditional diagnostic modalities include imaging (CT scan, contrast studies) and clinical assessment, but these may not detect subclinical leaks or early anastomotic stress. Recent studies have highlighted the role of biomarkers such as CRP, PCT, IL-6, and MMPs in the early detection of anastomotic compromise. Serial measurement of CRP and PCT in the early postoperative period has been shown to correlate with the development of leaks, with rising or persistently elevated levels suggesting ongoing anastomotic stress. Emerging markers such as microRNAs and tissue oxygenation indices are under investigation for their potential to provide even earlier and more precise detection.

Treatment & Management

Timely recognition of anastomotic stress allows for prompt intervention, ranging from enhanced surveillance and supportive care to reoperation or diversion. Biomarker-guided management protocols are being developed, incorporating trends in CRP, PCT, and other markers to inform clinical decision-making. For example, an early postoperative CRP value below a certain threshold may safely identify low-risk patients suitable for early discharge, whereas elevated or rising levels may prompt further imaging and close monitoring. Multidisciplinary collaboration among surgeons, intensivists, and laboratory specialists is crucial for the successful implementation of these strategies.

Recent Advances / Emerging Therapies

Recent research has expanded the repertoire of potential biomarkers, including fecal calprotectin, microRNAs, and cell-free DNA, which may provide greater specificity for anastomotic stress or mucosal injury. Point-of-care testing platforms are under development to facilitate rapid bedside assessment. Additionally, advances in intraoperative tissue oxygenation monitoring and the use of indocyanine green fluorescence angiography offer real-time assessment of tissue viability, complementing biochemical markers. Ongoing clinical trials are evaluating the integration of these tools into enhanced recovery after surgery (ERAS) protocols, with the goal of reducing complication rates and improving outcomes.

Guideline Recommendations

Several surgical societies now endorse the use of serial CRP measurements as part of routine postoperative monitoring for colorectal and other high-risk anastomoses. There is growing support for incorporating PCT and IL-6, particularly in complex cases or where sepsis is suspected. Guidelines emphasize the importance of combining biomarker trends with clinical judgment and imaging findings, rather than relying on any single parameter. Future updates are likely to include novel biomarkers as evidence for their clinical utility matures.

Conclusion

The identification and application of biomarkers of surgical anastomotic stress represent a significant advance in the perioperative management of patients undergoing major gastrointestinal and vascular procedures. While CRP and PCT remain the most widely validated markers, ongoing research into novel biomarkers and real-time assessment tools holds promise for further improving patient outcomes. Integration of biomarker-based strategies into clinical pathways, guided by evolving evidence and expert consensus, will be essential for optimizing the early detection, risk stratification, and management of anastomotic complications.